CN114934089B - Biological agent for lean pork pig breeding - Google Patents
Biological agent for lean pork pig breeding Download PDFInfo
- Publication number
- CN114934089B CN114934089B CN202210636477.3A CN202210636477A CN114934089B CN 114934089 B CN114934089 B CN 114934089B CN 202210636477 A CN202210636477 A CN 202210636477A CN 114934089 B CN114934089 B CN 114934089B
- Authority
- CN
- China
- Prior art keywords
- oligopeptide
- leafhopper
- small
- centrifuging
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000009395 breeding Methods 0.000 title claims abstract description 12
- 230000001488 breeding effect Effects 0.000 title claims abstract description 12
- 235000015277 pork Nutrition 0.000 title abstract description 8
- 239000003124 biologic agent Substances 0.000 title abstract description 4
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 63
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 63
- 241000086608 Empoasca vitis Species 0.000 claims abstract description 31
- 210000001789 adipocyte Anatomy 0.000 claims abstract description 24
- 239000002243 precursor Substances 0.000 claims abstract description 21
- 230000009815 adipogenic differentiation Effects 0.000 claims abstract description 10
- 108010016731 PPAR gamma Proteins 0.000 claims abstract description 7
- 102000000536 PPAR gamma Human genes 0.000 claims abstract description 6
- 241000282887 Suidae Species 0.000 claims abstract description 5
- 230000008021 deposition Effects 0.000 claims abstract description 5
- 241001414720 Cicadellidae Species 0.000 claims description 60
- 238000000855 fermentation Methods 0.000 claims description 15
- 230000004151 fermentation Effects 0.000 claims description 15
- 239000012528 membrane Substances 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 10
- 230000002401 inhibitory effect Effects 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 244000063299 Bacillus subtilis Species 0.000 claims description 8
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000526 Papain Proteins 0.000 claims description 8
- 239000004365 Protease Substances 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 229940088598 enzyme Drugs 0.000 claims description 8
- 238000004108 freeze drying Methods 0.000 claims description 8
- 230000000415 inactivating effect Effects 0.000 claims description 8
- 229940055729 papain Drugs 0.000 claims description 8
- 235000019834 papain Nutrition 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 239000002002 slurry Substances 0.000 claims description 8
- 238000000108 ultra-filtration Methods 0.000 claims description 8
- 239000003112 inhibitor Substances 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 abstract description 7
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- 102100034808 CCAAT/enhancer-binding protein alpha Human genes 0.000 abstract description 5
- 101710168309 CCAAT/enhancer-binding protein alpha Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 15
- 230000006698 induction Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 239000001963 growth medium Substances 0.000 description 9
- 235000013372 meat Nutrition 0.000 description 6
- 241000238631 Hexapoda Species 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 101000945515 Homo sapiens CCAAT/enhancer-binding protein alpha Proteins 0.000 description 4
- 230000002293 adipogenic effect Effects 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 3
- 239000002033 PVDF binder Substances 0.000 description 3
- 230000011759 adipose tissue development Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 210000004003 subcutaneous fat Anatomy 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 239000006180 TBST buffer Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 235000020997 lean meat Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 241000931705 Cicada Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000000431 effect on proliferation Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006303 immediate early viral mRNA transcription Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 125000003473 lipid group Chemical group 0.000 description 1
- 230000003520 lipogenic effect Effects 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0653—Adipocytes; Adipose tissue
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Water Supply & Treatment (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Fodder In General (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides a biological agent for lean pork pig breeding, and belongs to the technical field of pig breeding. The small green leafhopper oligopeptide is extracted from small green leafhoppers, and can remarkably inhibit lipid drop formation of pig precursor fat cells and expression of adipogenic differentiation related proteins PPARgamma and C/EBP alpha, so that the small green leafhopper oligopeptide can be used for breeding lean pigs to screen lean pigs with less fat deposition.
Description
The scheme is a divisional application, and the name of the original application is: an extract for inhibiting the differentiation of porcine precursor adipocytes, which is prepared by the following application days: 2020-10-15, the application number of the original application is: CN 202011100432.1.
Technical Field
The invention belongs to the technical field of pig breeding, and particularly relates to a biological agent for lean pig breeding.
Background
Along with the improvement of the living standard and the consumption level of people, the requirements on the quality of meat are also higher and higher, and the pork consumption is the first place in the meat consumption of the world as the country with the largest production and consumption of meat. The meat quality is an extremely important economic index in pork production, and the differentiation of fat cells and the deposition of lipid have important regulation and control effects on the meat quality of pork, and the inhibition of the differentiation of fat precursor fat cells to reduce the generation of subcutaneous fat has important value for improving the lean meat percentage of pork. Second, subcutaneous fat deposition is also an important factor affecting pig growth and meat quality, and is also of great concern in lean pig breeding. Therefore, finding a substance capable of effectively inhibiting the differentiation of pig precursor adipocytes has important research value for improving lean meat percentage of pork and pig breeding.
Insects are biological resources containing a large amount of high-quality proteins, insects are rich in various amino acids, peptides and proteins, and the existing researches prove that the insect peptide has various functions, so that it is feasible to search the insect for oligopeptides or polypeptides which can be used for pig precursor fat cells. Meanwhile, periostracum Cicadae and polypeptides thereof in the same cicada subgenera have been used for treating diseases, but little research on the same protein-rich leafhoppers is involved, so the invention selects the leafhoppers to study.
Disclosure of Invention
The invention aims to provide an extract capable of inhibiting adipogenic differentiation of porcine precursor adipocytes
In order to achieve the above purpose, the present invention provides the following technical solutions:
the invention provides an application of a small leafhopper extract in inhibiting adipogenic differentiation of pig precursor fat cells, wherein the small leafhopper extract is small leafhopper oligopeptide.
Preferably, the preparation method of the small leafhopper oligopeptide comprises the following steps:
(1) Removing wings of leafhopper, drying, and pulverizing into powder;
(2) Adding 5 times of water to obtain a uniform slurry of the leafhoppers;
(3) Inoculating 5% by weight of bacillus subtilis for fermentation for 48 hours;
(4) Sterilizing at high temperature and high pressure, and centrifuging to obtain fermentation supernatant;
(5) Adding papain 0.02 times of the total amount, fermenting at pH8.5 and 55deg.C for 48 hr;
(6) Inactivating enzyme at 95deg.C for 10min, and centrifuging to obtain green leafhopper oligopeptide solution;
(7) Filtering by using an ultrafiltration membrane with the molecular weight cut-off of 1kDa to obtain the small leafhopper oligopeptide;
(8) And (5) freeze-drying to obtain the finished product of the small leafhopper oligopeptide.
In addition, the invention provides application of the small green leafhopper extract in preparing an inhibitor for inhibiting adipogenic differentiation of pig precursor fat cells, wherein the small green leafhopper extract is small green leafhopper oligopeptide.
Preferably, the preparation method of the small leafhopper oligopeptide comprises the following steps:
(1) Removing wings of leafhopper, drying, and pulverizing into powder;
(2) Adding 5 times of water to obtain a uniform slurry of the leafhoppers;
(3) Inoculating 5% by weight of bacillus subtilis for fermentation for 48 hours;
(4) Sterilizing at high temperature and high pressure, and centrifuging to obtain fermentation supernatant;
(5) Adding papain 0.02 times of the total amount, fermenting at pH8.5 and 55deg.C for 48 hr;
(6) Inactivating enzyme at 95deg.C for 10min, and centrifuging to obtain green leafhopper oligopeptide solution;
(7) Filtering by using an ultrafiltration membrane with the molecular weight cut-off of 1kDa to obtain the small leafhopper oligopeptide;
(8) And (5) freeze-drying to obtain the finished product of the small leafhopper oligopeptide.
Preferably, the application comprises application of the small leafhoppers in preparing the genes PPARgamma and C/EBPalpha for inhibiting fat transformation.
In addition, the invention provides an inhibitor for inhibiting adipogenic differentiation of porcine precursor adipocytes, wherein the inhibitor is a green leafhopper oligopeptide.
Preferably, the preparation method of the small leafhopper oligopeptide comprises the following steps:
(1) Removing wings of leafhopper, drying, and pulverizing into powder;
(2) Adding 5 times of water to obtain a uniform slurry of the leafhoppers;
(3) Inoculating 5% by weight of bacillus subtilis for fermentation for 48 hours;
(4) Sterilizing at high temperature and high pressure, and centrifuging to obtain fermentation supernatant;
(5) Adding papain 0.02 times of the total amount, fermenting at pH8.5 and 55deg.C for 48 hr;
(6) Inactivating enzyme at 95deg.C for 10min, and centrifuging to obtain green leafhopper oligopeptide solution;
(7) Filtering by using an ultrafiltration membrane with the molecular weight cut-off of 1kDa to obtain the small leafhopper oligopeptide;
(8) And (5) freeze-drying to obtain the finished product of the small leafhopper oligopeptide.
In addition, the invention provides application of the small green leafhopper oligopeptide in lean pig breeding, and the preparation method of the small green leafhopper oligopeptide comprises the following steps:
(1) Removing wings of leafhopper, drying, and pulverizing into powder;
(2) Adding 5 times of water to obtain a uniform slurry of the leafhoppers;
(3) Inoculating 5% by weight of bacillus subtilis for fermentation for 48 hours;
(4) Sterilizing at high temperature and high pressure, and centrifuging to obtain fermentation supernatant;
(5) Adding papain 0.02 times of the total amount, fermenting at pH8.5 and 55deg.C for 48 hr;
(6) Inactivating enzyme at 95deg.C for 10min, and centrifuging to obtain green leafhopper oligopeptide solution;
(7) Filtering by using an ultrafiltration membrane with the molecular weight cut-off of 1kDa to obtain the small leafhopper oligopeptide;
(8) And (5) freeze-drying to obtain the finished product of the small leafhopper oligopeptide.
The invention has the beneficial effects that
The invention prepares the small green leafhopper oligopeptide from the small green leafhopper so as to recycle the insect small green leafhopper.
Secondly, the small green leafhopper oligopeptide prepared by the invention can obviously inhibit lipid drop formation of pig precursor adipocytes and can obviously inhibit expression levels of adipogenic differentiation related proteins PPARgamma and CEBP alpha, so that the small green leafhopper oligopeptide can be used for preparing inhibitors or medicines for inhibiting adipogenic differentiation of pig precursor adipocytes. Meanwhile, the method can be used for breeding lean pigs to screen lean pigs with less fat deposition.
Drawings
FIG. 1 control, 0ug/ml of the green leafhopper oligopeptide group, 150ug/ml of the green leafhopper oligopeptide group, oil red O staining results.
FIG. 2 control group, 0ug/ml of the small leafhopper oligopeptide group, 150ug/ml of the small leafhopper oligopeptide group, and the results of expression of the PPARgamma and CEBP alpha proteins of the fat transformation related proteins.
Detailed Description
In order to clearly illustrate the technical characteristics of the present solution, the present solution is described below by means of specific embodiments.
Example 1
(1) Cleaning the leafhoppers, putting the leafhoppers into a dryer for drying, and crushing the leafhoppers into powder by using a crusher;
(2) Adding 5 times of water, and fully and uniformly stirring to obtain a uniform slurry of the leafhopper;
(3) Inoculating 5% by weight of bacillus subtilis into the homogenate, fermenting for 48 hours at the pH of 7 and the temperature of 30 ℃;
(4) Sterilizing at 121deg.C under high temperature and pressure of 103.4kPa for 30min, centrifuging to obtain fermentation supernatant,
(5) Adding papain 0.02 times of the total amount, fermenting at pH8.5 and 55deg.C for 48 hr;
(6) Inactivating enzyme at 95deg.C for 10min, and centrifuging to obtain leafhopper peptide solution;
(7) Filtering by using an ultrafiltration membrane with the molecular weight cut-off of 1kDa to obtain a small leafhopper oligopeptide liquid;
(8) And (5) freeze-drying to obtain the finished product of the small leafhopper oligopeptide.
Example 2
Preparation of porcine precursor adipocytes
(1) Subcutaneous adipose tissue was collected from the back of 7-day-old piglets, washed 3 times with PBS containing the double antibody, and sheared into about 1mm using scissors 3 Is a block of tissue;
(2) Transferring the cut adipose tissues into a centrifuge tube, adding type I collagenase, digesting in a constant-temperature water bath at 37 ℃ for 90min, and adding a complete culture medium to stop digestion;
(3) Filtering the digestive juice by using a cell sieve of 80 meshes and a cell sieve of 200 meshes respectively, and collecting filtrate into a new sterile centrifuge tube;
(4) Placing the centrifuge tube in a centrifuge, centrifuging at 1500r/min for 10min, discarding the supernatant, adding erythrocyte lysate to the precipitate to suspend the cell precipitate, and centrifuging at 1500r/min for 5min;
(5) Removing the supernatant, adding PBS to wash the cells, and centrifuging at 1500r/min for 5min;
(6) Discarding the supernatant, adding DMEM complete medium to resuspend cells, inoculating into a cell culture dish at 37deg.C with 5% CO 2 Culturing in a cell incubator to obtain the pig precursor fat cells.
Example 3
(1) The green leafhopper oligopeptide prepared in example 1 was dissolved in DMEM to prepare 150ug/ml of green leafhopper oligopeptide solution, and the solution was subjected to sterilization filtration using a 0.22um filter membrane.
(2) Inoculating pig precursor fat cells into a 96-well plate, wherein a control group is not added with the small leafhopper oligopeptide, and an experimental group is added with 150ug/ml small leafhopper oligopeptide liquid;
(3) After 48h of incubation, OD values of the two groups of cells were determined with reference to CCK-8 instructions.
The experimental results are as follows, the OD value of the control group is 0.841+/-0.029,150, the OD value of the small leafhopper oligopeptide group is 0.875+/-0.025, and the P value is 0.426, and the difference is not statistically significant, so that the small leafhopper oligopeptide has no obvious effect on proliferation of pig precursor fat cells.
Example 4
Oil red O dyeing experiment
(1) Experimental grouping: the control group was not treated; adding 0ug/ml of the small leafhopper oligopeptide group into a lipid formation induction medium I and a lipid formation induction medium II to perform lipid formation induction, but not adding the small leafhopper oligopeptide; the 150ug/ml small leafhopper oligopeptides are used for adipogenesis induction by using an adipogenesis induction culture medium I and an adipogenesis induction culture medium II which are dissolved with 150ug/ml small leafhopper oligopeptides;
(2) Inoculating pig precursor fat cells into a cell culture plate, performing adipogenic induction culture according to experimental groups, firstly using adipogenic induction culture medium I to induce for 3 days, then using adipogenic induction culture medium II to induce for 2 days, and then changing to a complete culture medium;
(3) After adipogenic induction for 14 days, the culture medium is discarded, PBS is added for cleaning the cells for 3 times, 4% paraformaldehyde is added for cell fixation at room temperature after the excess PBS is sucked dry;
(4) After fixing for 20min, adding PBS to wash the cells for 3 times, adding oil red O staining solution, and incubating for 10min at room temperature;
(5) Cells were rinsed with PBS, observed under a microscope and photographed.
The experimental results are shown in fig. 1, and it can be seen from the graph that the quantity of the small leafhopper oligopeptides is obviously reduced compared with that of the small leafhopper oligopeptides with the ratio of 0ug/ml, so that the small leafhopper oligopeptides can inhibit the formation of lipid droplets of pig precursor fat cells, namely can inhibit the conversion of pig precursor fat cells into fat cells.
Example 5
(1) Cell grouping and lipogenic transformation were as in example 4;
(2) After the culture is finished, removing the culture medium, adding 1ml of PBS to wash the rest culture medium, discarding the PBS, adding 100ul of cell lysate, scraping off cells by using a cell scraper, and collecting the lysis mixture into an EP tube;
(3) Ultrasonically crushing cells, placing in a centrifuge, and centrifuging at 4deg.C and 12000rpm/min for 15min;
(4) After centrifugation, transferring the supernatant to a new centrifuge tube, measuring the protein concentration by using a BCA method, and adding a 5 XSDS loading buffer to adjust the protein sample concentration to 2ug/ml;
(5) Preparing 12% of separation gel and 5% of concentrated gel, adding 10ul of protein sample and protein marker, keeping constant pressure at 90V, changing into constant pressure at 120V after the separation gel, and stopping electrophoresis when bromophenol blue runs out of the separation gel;
(6) Taking out the gel, placing the film transfer clamp in an electric transfer tank according to a film transfer clamp according to a sandwich model, and electrically transferring the gel for 1.5 hours at room temperature and constant current of 250 mA;
(7) After the electric conversion is finished, taking out the PVDF film, putting the PVDF film into 5% skimmed milk powder, and sealing the PVDF film for 1h at room temperature;
(8) Membrane cutting according to the protein size, incubating PPARgamma, CEBP alpha and beta-actin, and incubating overnight at 4 ℃;
(9) Absorbing the primary antibody, washing the membrane 3 times by using TBST (Tunnel boring machine) for 10min each time, and incubating the secondary antibody for 1h at room temperature;
(10) The secondary antibody was discarded, and the membrane was washed 3 times with TBST, followed by development.
The experimental results are shown in fig. 2, and it can be seen from the graph that the small leafhopper oligopeptide can be obviously reversed to be converted into PPARgamma and CEBP alpha with increased protein expression amount caused by lipid conversion. Therefore, the green leafhopper oligopeptide can effectively inhibit the transformation of precursor adipocytes to adipocytes.
Claims (3)
1. The application of the small leafhopper oligopeptide in lean pig breeding is characterized in that the preparation method of the small leafhopper oligopeptide is as follows:
(1) Removing wings of leafhopper, drying, and pulverizing into powder;
(2) Adding 5 times of water to obtain a uniform slurry of the leafhoppers;
(3) Inoculating 5% by weight of bacillus subtilis for fermentation for 48 hours;
(4) Sterilizing at high temperature and high pressure, and centrifuging to obtain fermentation supernatant;
(5) Adding papain in an amount of 0.02 times, fermenting at pH8.5 and 55deg.C for 48 hr;
(6) Inactivating enzyme at 95deg.C for 10min, and centrifuging to obtain green leafhopper oligopeptide solution;
(7) Filtering by using an ultrafiltration membrane with the molecular weight cut-off of 1kDa to obtain the small leafhopper oligopeptide;
(8) Freeze-drying to obtain the finished product of the small leafhopper oligopeptide;
the green leafhopper oligopeptide can be used for screening lean pigs with less fat deposition.
2. An inhibitor for inhibiting adipogenic differentiation of porcine precursor adipocytes, wherein the inhibitor is a green leafhopper oligopeptide;
the preparation method of the green leafhopper oligopeptide comprises the following steps:
(1) Removing wings of leafhopper, drying, and pulverizing into powder;
(2) Adding 5 times of water to obtain a uniform slurry of the leafhoppers;
(3) Inoculating 5% by weight of bacillus subtilis for fermentation for 48 hours;
(4) Sterilizing at high temperature and high pressure, and centrifuging to obtain fermentation supernatant;
(5) Adding papain in an amount of 0.02 times, fermenting at pH8.5 and 55deg.C for 48 hr;
(6) Inactivating enzyme at 95deg.C for 10min, and centrifuging to obtain green leafhopper oligopeptide solution;
(7) Filtering by using an ultrafiltration membrane with the molecular weight cut-off of 1kDa to obtain the small leafhopper oligopeptide;
(8) And (5) freeze-drying to obtain the finished product of the small leafhopper oligopeptide.
3. The application of the small green leafhopper oligopeptide in preparing an inhibitor for inhibiting the expression of adipogenic differentiation related proteins in porcine precursor fat cells is characterized in that the adipogenic differentiation related proteins are PPARgamma and C/EBPalpha;
the preparation method of the green leafhopper oligopeptide comprises the following steps:
(1) Removing wings of leafhopper, drying, and pulverizing into powder;
(2) Adding 5 times of water to obtain a uniform slurry of the leafhoppers;
(3) Inoculating 5% by weight of bacillus subtilis for fermentation for 48 hours;
(4) Sterilizing at high temperature and high pressure, and centrifuging to obtain fermentation supernatant;
(5) Adding papain in an amount of 0.02 times, fermenting at pH8.5 and 55deg.C for 48 hr;
(6) Inactivating enzyme at 95deg.C for 10min, and centrifuging to obtain green leafhopper oligopeptide solution;
(7) Filtering by using an ultrafiltration membrane with the molecular weight cut-off of 1kDa to obtain the small leafhopper oligopeptide;
(8) And (5) freeze-drying to obtain the finished product of the small leafhopper oligopeptide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210636477.3A CN114934089B (en) | 2020-10-15 | 2020-10-15 | Biological agent for lean pork pig breeding |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210636477.3A CN114934089B (en) | 2020-10-15 | 2020-10-15 | Biological agent for lean pork pig breeding |
CN202011100432.1A CN112210529B (en) | 2020-10-15 | 2020-10-15 | Extract for inhibiting differentiation of pig precursor fat cells |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011100432.1A Division CN112210529B (en) | 2020-10-15 | 2020-10-15 | Extract for inhibiting differentiation of pig precursor fat cells |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114934089A CN114934089A (en) | 2022-08-23 |
CN114934089B true CN114934089B (en) | 2023-08-01 |
Family
ID=74054277
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210636477.3A Active CN114934089B (en) | 2020-10-15 | 2020-10-15 | Biological agent for lean pork pig breeding |
CN202011100432.1A Active CN112210529B (en) | 2020-10-15 | 2020-10-15 | Extract for inhibiting differentiation of pig precursor fat cells |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011100432.1A Active CN112210529B (en) | 2020-10-15 | 2020-10-15 | Extract for inhibiting differentiation of pig precursor fat cells |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN114934089B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105076676A (en) * | 2015-09-08 | 2015-11-25 | 南宁荣港生物科技有限公司 | Preparation method of polypeptide feed additive |
KR20180060066A (en) * | 2016-11-28 | 2018-06-07 | 재단법인 진안홍삼연구소 | Composition for preventing production of lipid and improving lipid metabolism using active ingredient with the extract of red ginseng |
CN109182382A (en) * | 2018-09-18 | 2019-01-11 | 嘉兴学院 | For inhibiting the substance of LGALS12 gene expression inhibiting the application in Adipocyte Differentiation |
CN111041052A (en) * | 2019-12-30 | 2020-04-21 | 嘉兴学院 | Application of mir-206 in inhibiting triglyceride generation in pig fat cells and lean pig breeding |
CN111454899A (en) * | 2020-04-30 | 2020-07-28 | 青岛思拓新源细胞医学有限公司 | Application of carrageenan in inhibiting mesenchymal stem cell lipogenesis transformation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5055611B2 (en) * | 1998-09-09 | 2012-10-24 | 学校法人日本大学 | Preadipocyte cell line |
CN106069459B (en) * | 2016-06-07 | 2020-01-31 | 王燕 | Method for cultivating peach blossom maze in southern high-temperature and high-humidity region |
-
2020
- 2020-10-15 CN CN202210636477.3A patent/CN114934089B/en active Active
- 2020-10-15 CN CN202011100432.1A patent/CN112210529B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105076676A (en) * | 2015-09-08 | 2015-11-25 | 南宁荣港生物科技有限公司 | Preparation method of polypeptide feed additive |
KR20180060066A (en) * | 2016-11-28 | 2018-06-07 | 재단법인 진안홍삼연구소 | Composition for preventing production of lipid and improving lipid metabolism using active ingredient with the extract of red ginseng |
CN109182382A (en) * | 2018-09-18 | 2019-01-11 | 嘉兴学院 | For inhibiting the substance of LGALS12 gene expression inhibiting the application in Adipocyte Differentiation |
CN111041052A (en) * | 2019-12-30 | 2020-04-21 | 嘉兴学院 | Application of mir-206 in inhibiting triglyceride generation in pig fat cells and lean pig breeding |
CN111454899A (en) * | 2020-04-30 | 2020-07-28 | 青岛思拓新源细胞医学有限公司 | Application of carrageenan in inhibiting mesenchymal stem cell lipogenesis transformation |
Also Published As
Publication number | Publication date |
---|---|
CN112210529A (en) | 2021-01-12 |
CN112210529B (en) | 2022-06-07 |
CN114934089A (en) | 2022-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110317847B (en) | Extract from animal tissue, and preparation method and application thereof | |
WO2010040262A1 (en) | Methods for isolating animal embryonic mesenchymal stem cells and extracting secretion substance thereof | |
CN109136174B (en) | Stem cell-derived exosome preparation for delaying senescence | |
CN113088487B (en) | Mesenchymal stem cell adipogenic transformation inhibitor | |
CN110669729A (en) | Method for preparing mesenchymal stem cell exosome | |
CN106591224B (en) | Method for separating and purifying high-purity chicken precursor intramuscular fat cells and constructing coculture system of high-purity chicken precursor intramuscular fat cells and muscle satellite cells | |
CN103223194A (en) | Cartilage graft for cartilage injury repair and preparation method thereof | |
CN114606186B (en) | Method for improving proliferation of umbilical cord mesenchymal stem cells | |
CN100564518C (en) | Placenta amnion cell extract and induce application in the differentiation at mescenchymal stem cell | |
CN112852717B (en) | Method for efficiently separating and culturing pig mammary gland epithelial cells | |
CN111903860B (en) | Application of moleplant seed extract in preparation of feed for promoting pig muscle development | |
CN114934089B (en) | Biological agent for lean pork pig breeding | |
CN112877287B (en) | Application of bullacta exarata polypeptide in preparation of osteogenic differentiation accelerant for mesenchymal stem cells | |
CN115478050B (en) | Method for improving stem cell in vitro amplification capacity | |
CN114836377B (en) | Stem cell in vitro osteogenic induction differentiation method | |
CN114939123A (en) | Therapeutic preparation for promoting wound repair | |
CN114276986A (en) | Method for separating and purifying buffalo primary myoblasts and application thereof | |
CN108210441A (en) | A kind of stem cell deep layer for cosmetology repairs Essence | |
CN113817792B (en) | Application of marine biological polypeptide in preparation of medicine for treating osteoporosis | |
CN112056463B (en) | Application of anemonin in improving quality of beef | |
CN111944761B (en) | Method for promoting differentiation and growth of epidermal stem cells | |
CN113717933B (en) | Application of FGF7 in preparation of stem cell expansion and phenotype maintaining reagent | |
CN114561355B (en) | Acute and rapid separation method for spinal cord scar tissue cells | |
CN116004518A (en) | Method for extracting and culturing human primary keratinocyte and fibroblast | |
CN114807005A (en) | Method for preparing matrigel by using animal carcasses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |